Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1994-12-20
1997-10-07
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242051, 4242291, 4352351, 4351723, 4353201, 4352523, 435325, 536 2372, A61K 3927, A61K 39295, C12N 700, C12N 510
Patent
active
056744994
ABSTRACT:
The present invention relates to an Equine herpesvirus (EHV) vaccine comprising an EHV having an insertion or deletion in the gene 15 of the EHV genome.
REFERENCES:
Matsumura et al., "DNA sequence and transcriptional analyses of the region of the Equine Herpesvirus type 1 Kentucky A strain genome encoding glycoprotein C," Virology, 193:2, Apr. 1993, pp. 910-923.
Nicolson et al., "The nucleotide sequence of the Equine Herpesvirus 4 gC gene homologue, " Virology, 179:2, Nov. 1990, pp. 378-387.
Telford et al. Virology 189:304-316, 1992.
Ostlund et al. Vet. Clin North Am Equine Pract Aug. 1993 vol. 9 (2): 283-294.
Nicolson Lesley
Sondermeijer Paulus Jacobus Antonius
Willemse Martha Jacoba
Akzo Nobel N.V.
Gormley Mary E.
Mosher Mary E.
Salimi Ali R.
LandOfFree
Equine herpesvirus gene 15 mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Equine herpesvirus gene 15 mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Equine herpesvirus gene 15 mutants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2354539